Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.6750
+0.0100 (1.50%)
Aug 27, 2026, 2:47 PM HKT

HKG:3737 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
161.56174.42167.1164.37381.01233.38
Short-Term Investments
-24.532.5925.6623.6615.67
Trading Asset Securities
---2.2814.698.8
Cash & Short-Term Investments
161.56198.92199.69192.3419.36257.85
Cash Growth
-8.36%-0.39%3.84%-54.14%62.64%-17.10%
Accounts Receivable
417.81441.76439.57327.99311.56293.56
Other Receivables
0.225.628.538.476.7113.88
Receivables
418.03447.38448.1336.46318.27307.44
Inventory
241.51280.59345.35330.02322.9268.06
Restricted Cash
49.4526.392.11---
Other Current Assets
-42.0818.8715.3430.3924.1
Total Current Assets
935.51995.361,014874.121,091857.44
Property, Plant & Equipment
650.5671.14730.44664.12573.6547.31
Long-Term Investments
82.969.7243.9549.3117.9117
Goodwill
1.631.631.631.631.631.63
Other Intangible Assets
7.018.3811.8514.2215.418.29
Long-Term Deferred Tax Assets
29.0429.7528.3530.0730.1931.97
Other Long-Term Assets
56.2355.51156.78159.17145.6150.47
Total Assets
1,7631,8311,9871,7931,8751,524

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
254.32261.6295.96190.97189.78120.83
Accrued Expenses
-43.9744.946.6689.8759.34
Short-Term Debt
----36.0357.24
Current Portion of Long-Term Debt
1012.0746.3327.33--
Current Portion of Leases
30.9931.2835.4348.2540.2137.87
Current Income Taxes Payable
32.1736.1644.9139.5830.7627.71
Current Unearned Revenue
2.3913.8913.7933.13134.9729.81
Other Current Liabilities
256.3222.57250.26222.68209.64168.02
Total Current Liabilities
586.16621.54731.56608.61731.25500.83
Long-Term Debt
-3638.2722.68--
Long-Term Leases
46.6550.6668.5776.5994.6280.62
Long-Term Unearned Revenue
4.515.437.9111.8715.8415.43
Long-Term Deferred Tax Liabilities
18.1418.0819.2619.5527.5926.06
Total Liabilities
655.45731.71865.58739.3869.31622.94

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
6.856.856.856.856.856.85
Additional Paid-In Capital
-25.0463.5986.73202.87202.87
Retained Earnings
-1,0401,022927.28764.51658.12
Comprehensive Income & Other
1,09623.0523.5927.6628.7530.9
Total Common Equity
1,1021,0951,1171,0491,003898.74
Minority Interest
55.055.024.822.972.43
Shareholders' Equity
1,1071,1001,1221,0531,006901.17
Total Liabilities & Equity
1,7631,8311,9871,7931,8751,524

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
87.63130.01188.6174.86170.86175.74
Net Cash (Debt)
73.9368.9111.0917.45248.582.1
Net Cash Growth
100.84%521.45%-36.45%-92.98%202.67%-33.32%
Net Cash Per Share
0.090.080.010.020.290.10
Filing Date Shares Outstanding
828.73863.6863.6863.6863.6863.6
Total Common Shares Outstanding
828.73863.6863.6863.6863.6863.6
Working Capital
349.35373.83282.56265.51359.67356.61
Book Value Per Share
1.331.271.291.211.161.04
Tangible Book Value
1,0941,0851,1031,033985.95878.82
Tangible Book Value Per Share
1.321.261.281.201.141.02
Buildings
-411.9271.57279.83268.41194.41
Machinery
-325.07268.92250.64221.23181.43
Construction In Progress
-15.04221.69110.5929.86116.37
Leasehold Improvements
-192192.2184.08187.73164.24